一家于2008年转向生物仿制制药的美国制药公司---默克公司认为进入生物仿制制药这个领域的障碍是如此之大以至于“只有几家”公司有能力成功进入。

Michael Kamarck of Merck, an American drugs firm which moved into biosimilars in 2008, thinks the barriers to entry are so great that “only a handful” of firms will be able to pull it off.

youdao

制药大亨们已经接受了国外品牌仿制药；同样的法则在这里同样适用，品牌仿制药有能力改变美国仿制药格局。

Big Pharma has already embraced branded generics abroad; the same principles apply here. Branded generics have the ability to change the US generics landscape.

youdao

企业的核心竞争力是由若干关键能力的有机组合，是排它的、其它企业无法购买、不能仿制的。

The key competition ability of enterprise is from some crucial ability have unit suit, queue up it 's, other enterprise can not purchase, can not copy.

youdao